Cite
HARVARD Citation
Porter, D. et al. (2015). 96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjects. HIV clinical trials. 16 (1), pp. 30-38. [Online].